Kallistatin levels in HIV-infected patients and effects of statin therapy.

about

Concentrations of Pro-Inflammatory Cytokines Are Not Associated with Senescence Marker p16INK4a or Predictive of Intracellular Emtricitabine/Tenofovir Metabolite and Endogenous Nucleotide Exposures in Adults with HIV Infection

P2860

Q28468505-3CD05ECA-822B-4CB0-8C29-CD8C73F9C002

P2860

Kallistatin levels in HIV-infected patients and effects of statin therapy.

Item

http://www.wikidata.org/entity/Q42101794

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Kallistatin levels in HIV-infected patients and effects of statin therapy.

@en

Kallistatin levels in HIV-infected patients and effects of statin therapy.

@nl

type

Item

label

Kallistatin levels in HIV-infected patients and effects of statin therapy.

@en

Kallistatin levels in HIV-infected patients and effects of statin therapy.

@nl

prefLabel

Kallistatin levels in HIV-infected patients and effects of statin therapy.

@en

Kallistatin levels in HIV-infected patients and effects of statin therapy.

@nl

P1476

Kallistatin levels in HIV-infected patients and effects of statin therapy.

@en

P2093

Allison Ross Eckard

http://www.w3.org/2001/XMLSchema#string

Grace A McComsey

http://www.w3.org/2001/XMLSchema#string

Mary Ann O'Riordan

http://www.w3.org/2001/XMLSchema#string

Soohee Cho

http://www.w3.org/2001/XMLSchema#string

P2860

Kallistatin is a potent new vasodilator

Inflammatory and coagulation biomarkers and mortality in patients with HIV infection

Novel role of kallistatin in protection against myocardial ischemia-reperfusion injury by preventing apoptosis and inflammation.

Kruppel-like factor 4 is a novel mediator of Kallistatin in inhibiting endothelial inflammation via increased endothelial nitric-oxide synthase expression.

The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals.

Plasma kallistatin levels in patients with severe community-acquired pneumonia.

Kallistatin inhibits vascular inflammation by antagonizing tumor necrosis factor-alpha-induced nuclear factor kappaB activation

Depletion of endogenous kallistatin exacerbates renal and cardiovascular oxidative stress, inflammation, and organ remodeling.

Kallistatin attenuates endothelial apoptosis through inhibition of oxidative stress and activation of Akt-eNOS signaling.

Kallistatin, a novel human tissue kallikrein inhibitor: levels in body fluids, blood cells, and tissues in health and disease.

P304

55-62

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/1354750X.2016.1204002

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-06-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27326658

http://www.w3.org/2001/XMLSchema#string

P921

statin therapy

P932

5576573

http://www.w3.org/2001/XMLSchema#string

Kallistatin levels in HIV-infected patients and effects of statin therapy.

about

P2860

P2860

Kallistatin levels in HIV-infected patients and effects of statin therapy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932